Differential Effects of 20‐Epi Vitamin D Analogs on the Vitamin D Receptor Homodimer
Open Access
- 1 April 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 14 (4) , 509-517
- https://doi.org/10.1359/jbmr.1999.14.4.509
Abstract
Vitamin D analogs have received increased attention because of their possible therapeutic benefits in treating osteoporosis and various proliferative disorders. Several analogs were examined for their effects on DNA binding of the vitamin D receptor (VDR) homodimer complex with the murine osteopontin vitamin D response element. All of the tested analogs increased complex binding by recombinant human VDR in the electrophoretic mobility shift assay and notable differences in mobility of these complexes were observed. A panel of C-terminal anti-VDR antisera were screened for their ability to interact with analog-bound VDR homodimer complexes or as a heterodimer complex with recombinant human retinoid X receptor α (rhRXRα). Like calcitriol, analog-bound heterodimer complexes were largely resistant to interaction with these antisera; however, striking differences were observed with the various antisera in an analogous homodimer binding experiment. KH1060 and CB1093, analogs with 20-epi conformations, produced homodimer complexes that were 3- to 6-fold more resistant to supershifting with Ab180 compared with the hormone or EB1089. Chymotrypsin digestion in combination with Western blotting using a C-terminal anti-VDR antiserum revealed similar digestion patterns for all ligands. However, KH1060- and CB1093-bound VDR complexes were more resistant to digestion than either calcitriol or EB1089. Finally, the ability of these compounds to yield stable homodimer complexes was assessed by challenging preformed homodimer with the exogenous addition of rhRXRα extracts. Although new heterodimer complexes appeared in a time-dependent fashion, the preformed homodimer complexes exhibited stable binding throughout the time course of the experiment. The results indicate that VDR homodimers are targets of vitamin D analogs with differential effects on C-terminal protein conformation that may partially explain the varied biological responses of these compounds.Keywords
This publication has 41 references indexed in Scilit:
- The phantom ligand effect: allosteric control of transcription by the retinoid X receptor.Genes & Development, 1997
- Proliferation and Differentiation of Cultured Human Keratinocytes is Modulated by 1,25(OH)2D3 and Synthetic Vitamin D3 Analogues in a Cell Density‐, Calcium‐ and Serum‐Dependent Manner*Basic & Clinical Pharmacology & Toxicology, 1997
- Vitamin D receptor interactions with the murine osteopontin response elementThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Synthetic 20‐Epi Analogs of Calcitriol are Potent Inducers of Target‐Gene Activation in Osteoblastic CellsEuropean Journal of Biochemistry, 1996
- Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and onin vitro bone resorptionThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Antiestrogens inhibit in vitro bone resorption stimulated by 1,25- dihydroxyvitamin D3 and the vitamin D3 analogs EB1089 and KH1060Endocrinology, 1995
- The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: Homodimers show higher ligand sensitivity than heterodimers with retinoid X receptorsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Vitamin D receptor binding and biological effects of cholecalciferol analogues in rat thyroid cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- 1,25-Dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of this residue promotes alternative phosphorylationBiochemistry, 1994
- POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATIONThe Lancet, 1989